More From GI21: Findings in Gastric Cancer, Cholangiocarcinoma, and Pancreatic Cancer
Release Date: 07/12/2023
IASLC WCLC 2020: Research in Mesothelioma, Small Cell Lung Cancer, and Drug Development
The ASCO Post Podcast
This week, we’re again focusing on research presented at the International Association for the Study of Lung Cancer 2020 World Conference on Lung Cancer Singapore, which was moved to a virtual format and held January 28 to 31, 2021, in light of the COVID-19 pandemic. We’ll hear about findings in mesothelioma, small cell lung cancer, and drug development.
info_outline
IASLC WCLC 2020: Updates From the ADAURA Trial and More
The ASCO Post Podcast
This week, we’re hearing from two thoracic oncologists on research presented at the International Association for the Study of Lung Cancer 2020 World Conference on Lung Cancer Singapore, which was moved to a virtual format and held January 28 to 31, 2021, in light of the COVID-19 pandemic.
info_outline
Prevalence of KRAS G12C Mutations Across Different Populations
The ASCO Post Podcast
This week, we’ll discuss the findings of a study that examined the prevalence of <i>KRAS</i> G12C mutations across different populations. Then, we’ll hear recent news about FDA oncology drug approvals in the month of January. Coverage of stories discussed this week on ascopost.com:
info_outline
More From GI21: Findings in Gastric Cancer, Cholangiocarcinoma, and Pancreatic Cancer
The ASCO Post Podcast
This week, we’re back for more coverage of the 2021 Gastrointestinal Cancers Symposium, hearing about the FIGHT trial in advanced gastric/gastroesophageal junction adenocarcinoma, the ClarIDHy study in IDH1-mutated cholangiocarcinoma, and the POLO trial in BRCA-mutated pancreatic cancer.
info_outline
Findings From the 2021 Gastrointestinal Cancers Symposium
The ASCO Post Podcast
The 2021 Gastrointestinal Cancers Symposium, held in a virtual format this year, is being held this weekend, January 15th to 17th, 2021. We’re discussing findings from the meeting with three study authors.
info_outline
IDEA Collaboration: 3 vs 6 Months of Adjuvant Chemotherapy for Patients With Advanced Colon Cancer
The ASCO Post Podcast
This week, we’ll review a meta-analysis of several trials studying the efficacy of 3 vs 6 months of adjuvant chemotherapy for patients with advanced colon cancer. We’ll also discuss a report on the frequency of osteonecrosis of the jaw among patients with metastatic bone disease treated with zoledronic acid, as well as several risk factors for the development of the condition. Coverage of stories discussed this week on ascopost.com:
info_outline
News From the 2020 San Antonio Breast Cancer Symposium
The ASCO Post Podcast
The San Antonio Breast Cancer Symposium took place virtually from December 8 to 12th. This week, we’re featuring three important studies from the meeting, focusing on a new prognostic tool; the treatment of depression and related symptoms in young breast cancer survivors; and a chemoimmunotherapy regimen for triple-negative disease.
info_outline
More News From ASH: Whole-Genome Sequencing of Myeloproliferative Neoplasms and More
The ASCO Post Podcast
This week, we’ll focus further on studies presented at the 2020 ASH Annual Meeting & Exposition, including findings on the use of whole-genome sequencing to trace the origins of a blood cancer; stem cell transplant for older patients with myelodysplastic syndromes; and a triplet therapy for relapsed and refractory multiple myeloma.
info_outline
News From the 2020 ASH Annual Meeting & Exposition
The ASCO Post Podcast
The 2020 ASH Annual Meeting & Exposition, held in a virtual format this year, begins today. We’re featuring three studies on the podcast this week from the meeting.
info_outline
COVID-19: Infection Rate Among Patients Undergoing Anticancer Therapy and Its Effect on Cancer Clinical Trials
The ASCO Post Podcast
As COVID-19 infection rates again spike around the nation, this week, we’re looking at two recent studies focused on COVID-19 and cancer. The first describes the rate of infection with the virus among asymptomatic patients with cancer undergoing active treatment for their solid tumors. The second explores how the ongoing pandemic is affecting the way patients with cancer choose to participate in clinical trials. Coverage of stories discussed this week on ascopost.com:
info_outlineThis week, we’re back for more coverage of the 2021 Gastrointestinal Cancers Symposium, hearing about the FIGHT trial in advanced gastric/gastroesophageal junction adenocarcinoma, the ClarIDHy study in IDH1-mutated cholangiocarcinoma, and the POLO trial in BRCA-mutated pancreatic cancer.